# Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

> **NCT01073566** · PHASE2 · COMPLETED · sponsor: **Calibra Medical, Inc.** · enrollment: 38 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Finesse
- **DEVICE:** Pen/Syringe (Usual injection device)

## Key facts

- **NCT ID:** NCT01073566
- **Lead sponsor:** Calibra Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-02-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01073566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01073566, "Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01073566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*